Status:
COMPLETED
Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)
Lead Sponsor:
University of California, Los Angeles
Conditions:
Children at Risk for ASD
Eligibility:
All Genders
12-21 years
Phase:
NA
Brief Summary
The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developin...
Detailed Description
The proposed intervention adapts a parent-mediated intervention that successfully improved outcomes in toddlers with autism. The intervention model (a) targets the foundations of social-communication ...
Eligibility Criteria
Inclusion
- Have elevated scores on the ADOS-Toddler version and clinical concern from professional (Pediatrician, Psychologist, etc). Because of the young age of children, we expect to intervene with children who do not yet have a diagnosis of ASD but may only show some risk by virtue of elevated scores on the ADOS-T.
- Have a parent available for parent-mediated sessions 2 times per week in the classroom
- Do not have seizures
- Do not have associated sensory or physical disorders
- Are not co-morbid with other syndromes or diseases
Exclusion
- Other co-morbid syndromes or diseases
- Seizure activity
- Other sensory or physical disorders
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01874327
Start Date
January 1 2013
End Date
September 1 2018
Last Update
October 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Semel Institue
Los Angeles, California, United States, 90024